Search results
This Pharma Stock Is Poised to Keep Outperforming the S&P 500
The Motley Fool via AOL· 5 days agoAstraZeneca has quietly delivered market-beating results since 2014. Despite skepticism, the company...
Generic-Drug Disputes Fuel New Jersey's Surge in Patent Litigation\t\t | New Jersey Law Journal
Law.com· 5 days agoNew Jersey’s federal courts are in the midst of a surge in patent litigation, driven by pharmaceutical companies’ claims of infringement against generic-drug producers. Plaintiffs ...
The 5 Stocks Defining 'The Year Of The Dividend' In 2024
Benzinga via Yahoo Finance· 21 hours agoReinvested stock dividends have significantly influenced the total return of the S&P 500 since 1927....
Pfizer Files Flurry of Lawsuits Over Migraine Medication Patent | Delaware Law Weekly
Law.com· 7 days agoPfizer recently filed at least seven lawsuits in federal court seeking to enjoin multiple multinational pharmaceutical companies from selling a generic version of its medication, Nurtec, which ...
Novartis stock rated 'Buy' by Goldman Sachs, highlighting robust innovation By Investing.com
Investing.com· 5 days agoThe coverage comes with the expectation that Novartis will maintain its robust execution up to...
2024 is being called ‘the year of the dividend.’ These 5 stocks keep on giving.
MarketWatch via Yahoo Finance· 3 days agoThey should be held as part of a broadly diversified portfolio, to reduce single-stock risk. 1....
This 5-Star Stock With a Dividend Yield That Tops 4% Is a Buy
Morningstar· 6 days agoGilead Sciences GILD has relied on its HIV and hepatitis C portfolio to drive profit margins. Gilead...
A year ago, Takeda pledged to create local jobs in exchange for $1.8 million in tax breaks. Now,...
The Boston Globe· 5 days agoThen last week Takeda said in a filing with the state that it planned to lay off 641 employees in...
Relief Therapeutics Announces Executive Changes
Morningstar· 1 day agoGENEVA, SWITZERLAND / ACCESSWIRE / June 3, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief Therapeutics, or the Company), a biopharmaceutical company committed ...
Nanoform's biologics technology showcased by large pharma at drug delivery conference;...
FOX 23 News Albany· 5 days agoManufacturing of GMP material in Project Nanoenzalutamide commenced. Fimea's two-day inspection of...
